RECENT NEWS ARTICLES

• October 03, 2011 - Kineta Scientists Present Novel Antiviral Research Findings at International Conference
  
  
• August 11, 2011 - Seattle Biotech Kineta gets NIH grant for virus drugs
  
  
• July 19, 2011 - Iacocca Family Foundation Adds to Kineta Investment
  
  
• July 5, 2011 - Investors Turn to Small Biotech to Speed Drug Development for Auto-immune Diseases
  
  
• April 11, 2011 - NIH Extends Kineta's Contract to Develop New Drug Candidates
  
  
• October 14, 2010 - Kineta Wins New NIH Contract Aimed at Speeding Development of Novel Drug Classes
  
  
• October 13, 2010 - Windhover Announces the 2011 "Top Biopharma Projects to Watch"
  
  
• June 7, 2010 - Seattle Times article on Kineta- Iacocca Foundation Partnership
  
  
• April / May 2010 - Kineta's Innovative Business Model Cited in Pharma Reformulates, Pharmaceutical Formulation and Quality
  
  
• November 10, 2009 - Xconomy, Kineta Rakes in Half of $13 Million Federal Contract
  
  
• November 1, 2009 - Start Up Profiles Kineta Business Model
  
  
• October 27, 2009 - Kineta Cuts a Deal with MPI Research, Xconomy
  
  
• August 1, 2009 - Pharmaceutical Executive Profiles Kineta in "Hot Biotech" Issue
  
  
• July 8, 2009 - Kineta Acquires Multiple Sclerosis, Diabetes Drug Candidate, Xconomy

PRESS RELEASES

2010

• June 7, 2010 - The Iacocca Family Foundation and Kineta Announce New Partnership on Type 1 Diabetes Mellitus Drug Development Program
  
  
• April 20, 2010 - Kineta Scientist to Present Novel Antiviral Research Findings at International Conference
  
  
• March 30, 2010 - Kineta Awarded NIH Grant to Complete Preclinical Studies on Type 1 Diabetes / Multiple Sclerosis Drug Candidate
  
  

2009

• December 10, 2009 - Kineta Partner Awarded UC Discovery Grant to Advance Preclinical Studies on Lead Autoimmune Therapeutic
  
  
• November 10, 2009 - Kineta, University of Washington partner on NIH-funded project to develop vaccine immune boosters
  
  
• October 27, 2009 - Kineta Announces Collaboration, Receives Funding and Investments for Multiple Programs
  
  
• July 7, 2009 - Kineta Acquires Novel Drug Candidates from Airmid for Potential Treatment of Multiple Sclerosis, Type 1 Diabetes and other Autoimmune Diseases
  
  
• March 15, 2009 - Kineta Inc. Executives Presenting at Invest Northwest
  
  
• February 9, 2009 - Ken North Named Senior Vice President of Finance
  
  

2008

• October 8, 2008 - Kineta Receives SBIR Funding to Begin Novel Antiviral Research
  
  

MEDIA KIT
For updates on Kineta or to schedule interviews, please contact Meg O'Conor by phone at 206-378-0400, or by email, moconor@kinetabio.com